第七届SAPA健康产业投资论坛项目路演

亲爱的SAPA会员和朋友，

多年来，美中药协通过每年夏季的SAPA健康产业投资论坛与项目路演(HIFnR)，成功促进了初创企业与知名投资机构间的合作。这一活动作为SAPA的旗舰项目之一，至今已连续举办了六届，孕育了数百个互利共赢的合作伙伴关系，并推动了制药和生物技术领域的创业与商业合作。

2024年，世界经济形势依然动荡，尤其是在生物医药领域中，资本寒冬尚未过去。业界资深人士大都以“谨慎的乐观”定调2024年生物医药产业的格局与发展。在这其中，并购和商务拓展(BD)交易巨增无疑是动荡市场的一剂强心针:各大制药公司开始频频出手收购小型生物科技制药公司，促成的商务合作创历史新高。在新的环境下，投资人和创业者该采取何种策略投融资？

第七届SAPA健康产业投资论坛与项目路演将于6月22日在New Brunswick, N举行。

活动亮点:

-众星云集:

本次盛会汇集了来自全球多家初创公司和知名投资及商务拓展公司的众多经验丰富的行业领导者，包括美国默克、百时美施贵宝(BMS)、武田(Takeda)、阿斯利康(AstraZeneca)等。重量级演讲嘉宾包括纽约证券交易所医疗健康行业主管Eric J. Dimise博士、Brii Bioscience创始人兼首席执行官Zhi Hong博士等。他们将慷慨分享在创业和投资趋势方面的独到见解和宝贵经验。

-创新遇见资本:

目前，已有约40个项目注册参与路演。本活动旨在为投资者和企业家提供交流平台，并为医疗健康行业的新兴企业提供有效的支持和解决方案。

-跟踪行业前沿发展，建立深度伙伴关系:

本次活动将包括全体会议、炉边畅谈、医疗创新路演、面对面交流、私人伙伴会议、创业指导等发展机会。

早年注册将于6月10日截止，活动常规注册将于6月19日截止, 我们诚邀观众尽早注册，抓住机遇，合作共赢。

活动信息

时间:

2024年6月22日，上午9:00 - 下午6:30(东部标准时间)

地点:

Hyatt Regency New Brunswick, 2 Albany St, New Brunswick, NJ 08901

观众注册

本次论坛欢迎观摩者参与，通过活动跟踪健康产业创投趋势，拓展人脉。观众将有机会聆听行业专家见解，了解最新的投资动向和创新项目，并与业内人士进行交流。早鸟注册将于6月10日截止。

注册费用

早鸟注册	SAPA 会员	$90
	非会员	$120
	VIP	$699
常规注册	SAPA 会员	$105
	非会员	$140
	VIP	$799
现场注册	SAPA 会员	$135
	非会员	$180
	VIP	$799
招待会	线上注册	$80
	现场注册	$95

VIP门票:通过我们的VIP套餐升级您的活动体验，包括优先准入,合作对接,以及个性化的会议服务。

折扣日间自助停车:每辆车$10刀

代客泊车:按现行费率收取停车费

完整演讲嘉宾

部分路演企业名单

论坛日程

注:具体日程安排和嘉宾请以活动网站为准

参与2024年论坛的投资人目录

– 社交媒体工具包–

根据以下链接可找到我们 SAPA-HQ 2024 HIFnR 社交媒体工具包:

这个工具包提供了可定制的社交媒体帖子、图形和其他模板，助您支持并分享对 2024 年 SAPA-HQ HIFnR 会议的热情。您及您的组织可在社交媒体和 SAPA-HQ 社区平台上使用这些信息，共同参与 #SAPA2024HIFnR。

– 关于 SAPA –

美中医药开发协会 成立于1993年，总部设在美国东部的药谷-新泽西州。SAPA自成立以来发展迅速，目前在美国和中国共有七个分会及6000多名会员，是美国最活跃的全国性华人专业协会之一。SAPA的会员主要来自美国大中型制药公司及生物技术公司。会员的专业技术领域涵盖整个医药产业研发和生产的每一个环节。在如此庞大的会员数量和高级科技人才的支持下，SAPA多年来不断地推动业界在传统制药、生物制药及仿制药方面的智慧交流。作为在美注册的非营利机构，SAPA长期以来得到美国及跨国公司的慷慨赞助和支持。SAPA将一如既往地为制药行业提供科技研讨、职业发展、知识培训、商业合作和创业投资的广阔平台。

– 欢迎加入 SAPA –

SAPA Healthcare Investment Forum Roadshow

Dear SAPA Members and Friends,

As a global organization for pharmaceutical professionals, the Sino-American Pharmaceutical Professionals Association spares no effort in promoting entrepreneurship, healthcare investment, and business cooperation in pharmaceuticals and biotechnology. Our 7th SAPA Healthcare Investment Forum Roadshow, a flagship event, aims to provide a premium platform for connecting investors and entrepreneurs and offer effective solutions and support to emerging enterprises in the healthcare industry.

In 2024, the global economic landscape remains volatile, particularly in the biopharmaceutical field, where the capital winter persists. Industry veterans describe 2024 with "cautious optimism" regarding the biopharmaceutical industry's structure and development. The surge in mergers and acquisitions and business development (BD) transactions serves as a vital boost to the turbulent market.

The 7th SAPA Healthcare Investment Forum Roadshow will be held on June 22nd at the Hyatt Regency in New Brunswick, NJ.

Event Highlights:

-A Gathering of Industry Leaders: This conference brings together numerous experienced industry leaders from multiple global startups and well-known investment and business development companies, including Merck, BMS, Takeda, AstraZeneca, and more.The keynote speakers include Dr. Eric J. Dimise, Sector Lead of Healthcare Life Sciences, Capital Markets at the New York Stock Exchange, and Dr. Zhi Hong, Founder and CEO of Brii Bioscience. They will generously share their unique insights and valuable experiences in entrepreneurship and investment trends.

-When Innovation Meets Capital:Currently, around 40 projects have registered to participate in the roadshow. This event aims to provide a platform for investors and entrepreneurs to communicate, and to offer effective support and solutions for emerging enterprises in the healthcare industry.

-Tracking Cutting-Edge Industry Developments and Building Deep Partnerships: The event will include plenary sessions, fireside chats, healthcare innovation roadshows, face-to-face exchanges, private partner meetings, entrepreneurship guidance, and other development opportunities.

Early bird registration closes on June 10th. Regular registration closes on June 19. So we warmly invite attendees to register early to seize opportunities and achieve collaborative success.

Event information:

Online Roadshow: June 14, 2024 , 8:00 PM - 9:30 PM (Eastern Standard Time)

Offline Conference and Roadshow: June 22, 2024 , 9:00 AM - 6:30 PM (Eastern Standard Time)

Venue for Offline Conference and Roadshow:

Hyatt Regency New Brunswick, 2 Albany St, New Brunswick, NJ 08901

– Confirmed Speakers Guests –

– Partial List of Roadshow Companies –

– Event Agenda–

Note: For the detailed schedule and guest list, please refer to the event website .

– List of Investor and Companies from 2024 HIFnR –

– Registration Information –

In-person conference registration, click HERE

Early Registration	SAPA Member	$90
	Non-member	$120
	VIP	$699
Regular Registration	SAPA Member	$105
	Non-member	$140
	VIP	$799
On-site Registration	SAPA Member	$135
	Non-member	$180
	VIP	$799
Reception	Online Registration	$80
	On-site Registration	$95

VIP ticket: Elevate your event experience with our VIP package, which includes priority access to partnering and personalized conference support.

Discounted Daily Self-Parking: $10 per vehicle

Valet Parking: Charged at prevailing rates; individuals responsible for their own parking fees

The online roadshow will be held on Friday, June 14, 2024, from 8:00 PM to 9:30 PM .Please scan the QR code below to register for the Online Roadshow for free:

-Social Media Toolkit-

This toolkit provides customizable social media posts, graphics, and other templates to help you support and share your excitement for the 2024 SAPA HIFnR Conference. You and your organization can use this content on social media and the SAPA- HQ community platform, joining together with #SAPA2024HIFnR.

– About SAPA –

The Sino-American Pharmaceutical Professionals Association was established in 1993 and is headquartered in the center of the pharmaceutical corridor in New Jersey, USA. Since its inception, SAPA rapidly became one of the most active Chinese professional associations in the US with seven chapters and more than 6,000 members

SAPA’s members are primarily from large and mid-sized pharmaceutical and biotech companies in the US, with areas of expertise covering almost every aspect of pharmaceutical research and development as well as production

The organization’s large membership base and superb scientific and technical abilities has allowed SAPA to be a key source for knowledge exchange on the latest developments in the pharmaceutical, biotechnology, and generic drug industries

As a non-profit organization registered in the US, SAPA receives generous sponsorship and support from numerous multinational companies in the US and overseas. SAPA will continue to provide a broad platform for scientific and technical discussion, talent exchange, and training for colleagues in the pharmaceutical industry from the US and China

– Welcome to Join Us –